Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Current Opinion in Hematology|January 29, 2014
Graft-versus-host disease: why have we not made more progress?Samantha M Jaglowski, Steven M DevineSeminars in Hematology|March 31, 2010
Rituximab in chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdBlood Advances|August 16, 2018
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHDSamantha M Jaglowski, Bruce R BlazarCells|June 19, 2024
The Evolution of Hematopoietic Stem Cell Transplantation to Overcome Access Disparities: The Role of NMDPSteven M DevineJournal of Cellular Biochemistry. Supplement|June 6, 2002
Mesenchymal stem cells: will they have a role in the clinic?Steven M DevineBritish Journal of Haematology|July 27, 2012
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaSamantha M Jaglowski, Amy S Ruppert, Nyla A Heerema, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 9, 2016
Ibrutinib for treatment of chronic lymphocytic leukemiaCory M Vela, Ali McBride, Samantha M Jaglowski, et al.Seminars in Oncology|October 20, 2009
Lymphoma in adolescents and young adultsSamantha M Jaglowski, Erica Linden, Amanda M Termuhlen, et al.Pageof 18